Globeflex Capital’s Theravance Biopharma TBPH Stock Holding History

Globeflex Capital’s Portfolio TBPH Stock Details TBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$179K	Hold	10,512	–	–	0.02%	321
2026 Q1	$171K	Buy	+10,512	New	+$186K	0.03%	315

Other funds holding TBPH

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

ICM

Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Globeflex Capital's TBPH Position: Q2 2026 in Review

Globeflex Capital held its Theravance Biopharma (TBPH) position steady in Q2 2026 at 10,512 shares worth $179K. The position accounts for 0.02% of the portfolio, ranked #321.

Globeflex Capital first reported a position in TBPH in Q1 2026 and has held it in 2 quarters since. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

Globeflex Capital held 10,512 shares of Theravance Biopharma worth $179K as of Q2 2026.
Globeflex Capital left its Theravance Biopharma share count unchanged in Q2 2026.
Theravance Biopharma made up 0.02% of Globeflex Capital's portfolio in Q2 2026, its #321 holding.
Globeflex Capital first reported a position in Theravance Biopharma in Q1 2026 and has held it in 2 quarters since.
180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.